美东时间2020年5月18日,ZNTL股价今开37.5000美元,盘中最高40.4450美元,盘中最低36.4000美元,股价收涨10.54%,涨3.7800点,报39.6500美元

ZNTL简介

Zentalis Pharmaceuticals, LLC is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It use its highly efficient drug discovery engine, which it refer to as its Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believe could result in potentially differentiated product profiles. Its discovery engine combines its extensive experience and capabilities across cancer biology and medicinal chemistry.